Junctional adhesion molecules in angiogenesis.

The process of new blood vessel formation from pre-existing vessels is known as angiogenesis. This process is important, both during physiological processes such as development and during wound healing, as well as during pathological processes, such as cancer and arthritis. Understanding the molecular mechanism of the regulation of angiogenesis and the identification of the key players involved in this process may help identify new therapeutic targets to combat and control angiogenesis and hence arthritis and cancer. This review focuses on a recently identified novel cell adhesion molecule, Junctional Adhesion Molecule A, and its role in the process of regulating angiogenesis.

[1]  U. Naik,et al.  Fibroblast Growth Factor-2 Failed to Induce Angiogenesis in Junctional Adhesion Molecule-A–Deficient Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[2]  W. Skarnes,et al.  JAM‐A expression during embryonic development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[3]  M. Aurrand-Lions,et al.  Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. , 2005, Cancer research.

[4]  Ruslan Hlushchuk,et al.  Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[5]  H. T. Yang,et al.  What makes vessels grow with exercise training? , 2004, Journal of applied physiology.

[6]  Deepika Vuppalanchi,et al.  Essential Role of Junctional Adhesion Molecule-1 in Basic Fibroblast Growth Factor–Induced Endothelial Cell Migration , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  U. Naik,et al.  Junctional adhesion molecule 1 (JAM-1). , 2003, Journal of biological regulators and homeostatic agents.

[8]  W. Muller.  Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. , 2003, Trends in immunology.

[9]  T. R. Peters,et al.  Crystal structure of human junctional adhesion molecule 1: Implications for reovirus binding , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Hruska,et al.  The Integrin {alpha}v{beta}3 and CD44 Regulate the Actions of Osteopontin on Osteoclast Motility , 2003, Calcified Tissue International.

[11]  S. Cunningham,et al.  JAM2 interacts with alpha4beta1. Facilitation by JAM3. , 2002, The Journal of biological chemistry.

[12]  M. Aurrand-Lions,et al.  Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. , 2001, Blood.

[13]  A. Montgomery,et al.  Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. , 2001, Molecular biology of the cell.

[14]  F. Winkler,et al.  X‐ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif , 2001, The EMBO journal.

[15]  P. Martin-DeLeon,et al.  Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody. , 2001, Journal of cell science.

[16]  H. Aaron,et al.  Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. , 2000, American journal of physiology. Cell physiology.

[17]  D. Cheresh,et al.  Role of alpha v integrins during angiogenesis. , 2000, Cancer journal.

[18]  J. Hartwig,et al.  Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. , 2000, Blood.

[19]  N. Hogg,et al.  Identification and characterisation of human Junctional Adhesion Molecule (JAM). , 1999, Molecular immunology.

[20]  T. Kita,et al.  Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. , 1999, Journal of immunology.

[21]  R. Hynes,et al.  Integrins in vascular development. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[23]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[24]  U. Naik,et al.  Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor. , 1995, The Biochemical journal.

[25]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[26]  A. Logan,et al.  Angiogenesis , 1993, The Lancet.

[27]  U. Naik,et al.  Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. , 2006, Journal of cell science.

[28]  P. Nawroth,et al.  The role of junctional adhesion molecules in cell-cell interactions. , 2005, Histology and histopathology.

[29]  平林 享.  JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1 , 2004 .

[30]  S. Mousa,et al.  Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. , 2003, Blood.

[31]  J R Izbicki,et al.  Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. , 1999, Pancreas.

[32]  D. Cheresh,et al.  Definition of two angiogenic pathways by distinct alpha v integrins. , 1995, Science.

[33]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.